DE3583484D1 - Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii). - Google Patents

Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii).

Info

Publication number
DE3583484D1
DE3583484D1 DE8585902327T DE3583484T DE3583484D1 DE 3583484 D1 DE3583484 D1 DE 3583484D1 DE 8585902327 T DE8585902327 T DE 8585902327T DE 3583484 T DE3583484 T DE 3583484T DE 3583484 D1 DE3583484 D1 DE 3583484D1
Authority
DE
Germany
Prior art keywords
retrovers
htlv
aids
iii
cell line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585902327T
Other languages
English (en)
Inventor
C Gallo
Mikulas Popovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/602,946 external-priority patent/US4647773A/en
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE3583484D1 publication Critical patent/DE3583484D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10051—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8585902327T 1984-04-23 1985-04-23 Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii). Expired - Lifetime DE3583484D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/602,946 US4647773A (en) 1984-04-23 1984-04-23 Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
US06/643,729 US4652599A (en) 1984-04-23 1984-08-24 Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
PCT/US1985/000720 WO1985004897A1 (en) 1984-04-23 1985-04-23 Method and cell line for continuous production of retroviruses (htlv-iii) related to aids

Publications (1)

Publication Number Publication Date
DE3583484D1 true DE3583484D1 (de) 1991-08-22

Family

ID=27084286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585902327T Expired - Lifetime DE3583484D1 (de) 1984-04-23 1985-04-23 Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii).

Country Status (13)

Country Link
US (1) US4652599A (de)
EP (1) EP0179871B1 (de)
JP (1) JP2686892B2 (de)
KR (1) KR910003916B1 (de)
AU (1) AU560887B2 (de)
CA (1) CA1266243A (de)
DE (1) DE3583484D1 (de)
GR (1) GR850975B (de)
IE (1) IE58320B1 (de)
IL (1) IL74994A (de)
NZ (1) NZ211859A (de)
SG (1) SG34892G (de)
WO (1) WO1985004897A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
NZ211860A (en) * 1984-04-23 1990-10-26 Us Health Method for detection of hiv; test kit
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
US7285271B1 (en) 1984-10-31 2007-10-23 Novartis Vaccines And Diagnostics, Inc. Antigenic composition comprising an HIV gag or env polypeptide
CA1341482C (en) 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
US7393949B1 (en) 1987-12-24 2008-07-01 Novartis Vaccines And Diagnostics, Inc. Human immunodeficiency virus (HIV) nucleotide sequences
US7273695B1 (en) * 1984-10-31 2007-09-25 Novartis Vaccines And Diagnostics, Inc. HIV immunoassays using synthetic envelope polypeptides
HU204929B (en) * 1985-01-15 1992-02-28 Cancer Res Inst Method and test set for detecting antibodies of aids retrovirus, as well as producing the retrovirus
GB8500918D0 (en) * 1985-01-15 1985-02-20 Cancer Res Inst Viral isolates
US5176995A (en) * 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
US5386022A (en) * 1985-03-28 1995-01-31 Hoffman-La Roche Inc. Primes and probes for the amplification and detection of aids associated nucleic acids
EP0220970B1 (de) * 1985-09-13 1996-01-10 Institut Pasteur Methoden zur Verwendung von an humanen Klasse-II-Histokompatibilitätsantigenen mangelnden Zellinien
FR2597500B1 (fr) * 1986-03-24 1989-06-02 Pasteur Institut Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US5079342A (en) * 1986-01-22 1992-01-07 Institut Pasteur Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
FR2596063B1 (fr) * 1986-03-18 1989-05-19 Pasteur Institut Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US5830641A (en) * 1986-01-22 1998-11-03 Institut Pasteur In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies
US5306614A (en) * 1986-01-22 1994-04-26 Institut Pasteur Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2)
FR2594229B1 (fr) * 1986-02-13 1989-05-19 Pasteur Institut Nouveau retrovirus du type lav-ii susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
PT84182B (pt) * 1986-01-22 1989-09-14 Pasteur Institut Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"
FR2593189B1 (fr) * 1986-01-22 1989-10-20 Pasteur Institut Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US5364933A (en) 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
FR2593190B1 (fr) * 1986-01-22 1989-10-20 Pasteur Institut Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US5580739A (en) 1986-01-22 1996-12-03 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
US5976785A (en) * 1986-01-22 1999-11-02 Institut Pasteur Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US7115363B1 (en) 1986-01-22 2006-10-03 Institut Pasteur Retrovirus capable of causing AIDS, means and methods for detecting it in vitro
US4753873A (en) * 1986-02-03 1988-06-28 Cambridge Bioscience Corporation Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
US6054565A (en) 1986-03-03 2000-04-25 Institut Pasteur Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
FR2599756A1 (fr) * 1986-06-10 1987-12-11 Pasteur Institut Mitogenes streptococciques specifiques des lymphocytes t4, leur application a la stimulation de la production de virus lav
EP0269520A3 (de) * 1986-11-21 1988-08-24 Institut Pasteur Zum Hervorrufen von AIDS geeignetes Retrovirus vom HIV-2-Typ sowie seine Antigen- und Nukleinsäurebestandteile
SE8605535L (sv) * 1986-12-22 1988-06-23 Birgitta Asjo Cellsystem, dess framstellning och anvendning
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
JP2810179B2 (ja) * 1988-08-16 1998-10-15 アクゾ・エヌ・ヴエー 天然型ｈｉｖ ｇｐ１６０の製造方法

Also Published As

Publication number Publication date
IE58320B1 (en) 1993-09-08
JPH0670759A (ja) 1994-03-15
AU560887B2 (en) 1987-04-16
US4652599A (en) 1987-03-24
IE851021L (en) 1985-10-23
GR850975B (de) 1985-11-25
EP0179871B1 (de) 1991-07-17
IL74994A (en) 1988-11-30
IL74994A0 (en) 1985-08-30
CA1266243A (en) 1990-02-27
KR860700044A (ko) 1986-01-31
AU4292685A (en) 1985-11-15
NZ211859A (en) 1989-05-29
JP2686892B2 (ja) 1997-12-08
SG34892G (en) 1992-05-22
EP0179871A1 (de) 1986-05-07
WO1985004897A1 (en) 1985-11-07
EP0179871A4 (de) 1986-09-04
KR910003916B1 (ko) 1991-06-15

Similar Documents

Publication Publication Date Title
DE3583484D1 (de) Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii).
DE3587787D1 (de) Verfahren zur Herstellung von Hohlfasern.
ATE44735T1 (de) Verfahren zur herstellung von (threo)-1-aryl-2acylamido-3-fluoro-1-propanole.
AT385282B (de) Verfahren zur kontinuierlichen herstellung von aethanol
ATE66678T1 (de) Verfahren zur herstellung von makrolidderivaten.
DE3689259D1 (de) Verfahren zur Herstellung von Polyolefinen.
DE3586516D1 (de) Verfahren zur herstellung von maleimiden.
DE3587402D1 (de) Verfahren zur herstellung von piperidinderivaten.
DE3672942D1 (de) Verfahren zur herstellung von tetrafluorbenzoesaeure.
DE3583171D1 (de) Verfahren zur herstellung von kohlenstoffkoerpern.
ATE38832T1 (de) Verfahren zur herstellung von pyrrolidonderivaten.
DE3776173D1 (de) Verfahren zur herstellung von saeureamiden.
DE3677401D1 (de) Verfahren zur herstellung von perylen-3,4,9,10-tetracarbonsaeurearylimiden.
DE3862774D1 (de) Verfahren zur herstellung von vinylphosphonsaeuredialkylestern.
DE3773522D1 (de) Verfahren zur kontinuierlichen herstellung von phthalodinitril.
DE3880902D1 (de) Verfahren zur herstellung von hydroxybenzoesaeure.
DE58901937D1 (de) Elektrochemisches verfahren zur herstellung von chromsaeure.
ATE65259T1 (de) Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii).
DE3575556D1 (de) Verfahren zur herstellung von 2-phenylbenztriazolen.
DE3579392D1 (de) Verfahren zur mikrobiologischen herstellung von aldose-1-epimerase.
AT381929B (de) Verfahren zur herstellung von succinylobernstein- saeuredialkylestern
DE3764546D1 (de) Verfahren zur kontinuierlichen herstellung von phthalodinitril.
ATE32703T1 (de) Verfahren zur herstellung von cycloalkadienen.
ATE49234T1 (de) Verfahren zur herstellung von festuclavin.
ATE40901T1 (de) Verfahren zur herstellung von chanoclavin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition